Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Stopping unwanted cell death: novel avenue for drug development

Stopping unwanted cell death: novel avenue for drug development

ImClone Systems enrols first patient in clinical trial of IMC-1121B to treat liver cancer

ImClone Systems enrols first patient in clinical trial of IMC-1121B to treat liver cancer

Novel anti-tumor compound

Novel anti-tumor compound

Sunitinib may be associated with cardiac toxicity

Sunitinib may be associated with cardiac toxicity

Bosutinib safe, effective for chronic myelogenous leukemia

Bosutinib safe, effective for chronic myelogenous leukemia

Data confirm Dasatinib's effectiveness in resistant chronic myelogenous leukemia

Data confirm Dasatinib's effectiveness in resistant chronic myelogenous leukemia

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

SuperGen's CLIMB technology identifies lead Pim kinase inhibitors

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

U.S. approval of Nexavar (sorafenib) for inoperable liver cancer

Enzyme sphingosine kinase 2 show to be potential new target to fight cancer

Enzyme sphingosine kinase 2 show to be potential new target to fight cancer

Blood markers can help choose best dose for antiangiogenic drugs

Blood markers can help choose best dose for antiangiogenic drugs

New target for Hepatocellular carcinoma therapy

New target for Hepatocellular carcinoma therapy

Combination targets offer new hope in fight against cancer

Combination targets offer new hope in fight against cancer

Novel strategy to tackle acute myelogenous leukemia

Novel strategy to tackle acute myelogenous leukemia

Study suggests brain tumors need treatment with multiple 'targeted' drugs

Study suggests brain tumors need treatment with multiple 'targeted' drugs

Congestive heart failure is rare among leukemia patients who take imatinib

Congestive heart failure is rare among leukemia patients who take imatinib

Genetics of imatinib resistance in acute lymphoblastic leukemia

Genetics of imatinib resistance in acute lymphoblastic leukemia

Potential new leukemia drug

Potential new leukemia drug

Current status of neuroblastoma treatment and trends for the near future

Current status of neuroblastoma treatment and trends for the near future

More effective therapies for individual cancers  - personalized medicine

More effective therapies for individual cancers - personalized medicine

Scientists tackle cancer with different approaches

Scientists tackle cancer with different approaches